Good evening :)
$
₹
Johnson & Johnson

Johnson & Johnson

JNJ

NYSE
Asset Logo

Johnson & Johnson

JNJ

NYSE
$270.690.25% (+0.69)
$
₹
$270.690.25% (+0.69)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Drug Manufacturers - General

Mega Cap

With a market cap of $650.6B the stock is ranked 22

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

31.35
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

7.65
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$8.61
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

2.83
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

21.48%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1.94%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 24 analysts' reports

Buy
11 analysts
Hold
13 analysts
Sell
0 analyst

Analysts expect a +2.85% price upside over the next year

Current Price$270.69
Target Price$277.90

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Peers

Peers

Eli Lilly and Company
LLY
Eli Lilly and Company
P/E Ratio
38.75
38.75
1Y Return
51.34%
51.34%
Buy Reco %
77.41
77.41
Merck & Company Inc
MRK
Merck & Company Inc
P/E Ratio
117.49
117.49
1Y Return
80.14%
80.14%
Buy Reco %
57.69
57.69
Novartis AG ADR
NVS
Novartis AG ADR
P/E Ratio
21.17
21.17
1Y Return
14.78%
14.78%
Buy Reco %
15.38
15.38
AstraZeneca PLC
AZN
AstraZeneca PLC
P/E Ratio
24.86
24.86
1Y Return
8.31%
8.31%
Buy Reco %
90.00
90.00
Novo Nordisk A/S
NVO
Novo Nordisk A/S
P/E Ratio
10.72
10.72
1Y Return
30.08%
30.08%
Buy Reco %
41.66
41.66

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - General

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Johnson & Johnson 31.357.652.83
Eli Lilly and Company38.7530.331.13
Merck & Company Inc117.498.642.68

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

23.9
5.1
24.5
5.1
24
5.2
25.3
5.5
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue21.3822.4422.4722.5221.8923.7423.9924.5624.0625.31
Net Income3.254.682.693.4310.995.535.155.115.235.53
Net Profit Margin15.22%20.87%11.98%15.23%50.23%23.32%21.47%20.82%21.75%21.86%
See CostsAll values in $ Billion

Frequently asked questions

  1. Johnson & Johnson (JNJ) share price today is $270.69 as of September 21, 2026 at 10:32 PM IST. The stock touched a day high of $273.57 and a day low of $268.77.

  2. Johnson & Johnson stock trades on NYSE under the ticker symbol JNJ.

  3. Johnson & Johnson's market capitalization is $650.64B as of September 21, 2026 at 10:32 PM IST.

  4. Johnson & Johnson's price-to-earnings (P/E) ratio is 31.35 as of September 21, 2026.

  5. Johnson & Johnson's price-to-book (P/B) ratio is 7.65 as of September 21, 2026.

  6. Yes, Johnson & Johnson pays a dividend, with a current dividend yield of 1.94%.

  7. Yes, You can buy Johnson & Johnson shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Johnson & Johnson shares in three steps: 1. Search Johnson & Johnson on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Johnson & Johnson trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Johnson & Johnson (JNJ) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0369 shares at the current price of $270.69.

Loading...